A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer

OBJECTIVE: Significant efforts are currently being made to identify novel biomarkers for the diagnosis and risk stratification of prostate cancer (PCa). Metabolomics can be a very useful approach in biomarker discovery because metabolites are an important read-out of the disease when characterized i...

Descripción completa

Detalles Bibliográficos
Autores principales: Drago, Denise, Andolfo, Annapaola, Mosca, Ettore, Orro, Alessandro, Nocera, Luigi, Cucchiara, Vito, Bellone, Matteo, Montorsi, Francesco, Briganti, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185872/
https://www.ncbi.nlm.nih.gov/pubmed/34037347
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185872/
https://www.ncbi.nlm.nih.gov/pubmed/34037347
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0617

Ejemplares similares